Oct 21, 20213 min readCANCER RESEARCHToripalimab joins the list of ICIs that improve efficacy when added to chemotherapy in 1L NSCLC
Sep 10, 20213 min readCANCER RESEARCHIpilimumab-nivolumab combo as 2L does not improve survival for immunotherapy naive NSCLC